POP-OUT | CLOSE
 
HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
Sequence Clustering and Redundancy Reduction Results
1G9N
Cluster # 4 Members. Sequence cutoff: 90% Cluster size: 366 sequences
Rank   PDB id Entity id Chains Description Details Taxonomy EC Number
Select for download / view details OR: Select two chains for comparison
  Download      Details  
1 4NZU 1 L 13PL heavy chain Fab 9606  
2 2VXV 2 L HUMAN IGG ABT-325 9606  
3 4HS6 2 A, L MRCT10.v362 Fab light chain 9606  
4 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090  
5 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
6 3QQ9 1 C, L 101F LIGHT CHAIN 10090  
7 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606  
8 3QRG 1 L Fab light chain 9606  
9 3NCJ 1 L Fab15 Mut8 light chain 9606  
10 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
11 3NA9 1 L Fab15 light chain 9606  
12 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
13 4HHA 1 A Fab KE5 Fab fragment KE5 9606  
14 3NAA 1 L Fab15 Mut5 light chain 9606  
15 4PUB 2 L DX-2930 LIGHT CHAIN 9606  
16 3OAZ 2 K, L Fab 2G12, light chain 9606  
17 3EO0 1 A, C GC-1008 Fab Light Chain 10090  
18 4JHA 2 L D25 light chain 9606  
19 4DGV 2 L HCV1 Light Chain 9606  
20 3IU4 2 L chP3 Fab light chain 10090  
21 3P0Y 3 L Fab DL11 light chain 9606  
22 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606  
23 3NAC 1 L Fab15 Mut7 light chain 9606  
24 4DGY 2 L HCV1 Light Chain 9606  
25 3MXW 2 L 5E1 light chain 9606  
26 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630  
27 3EO9 1 L Efalizumab Fab fragment, light chain 9606  
28 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
29 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606  
30 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606  
31 2FX7 1 L Fab 4E10 Light Chain 9606  
32 3SOB 1 L antibody light chain 9606  
33 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090  
34 4KQ3 1 L CNTO3186 light chain Fab 9606  
35 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
36 4I77 2 L Lebrikizumab light chain Fab 9606  
37 4HJG 1 A Trastuzumab light chain 9606  
38 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
39 3FN0 1 L Fab Z13e1 light chain 9606  
40 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090  
41 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090  
42 4MAU 1 L C2244 light chain SEE REMARK 999 10090  
43 1OP3 1 K, L FAB 2G12, light chain light chain 9606  
44 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606  
45 3QWO 1 B, L motavizumab light chain 10090  
46 4IOI 1 A Trastuzumab light chain 9606  
47 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090  
48 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090  
49 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606  
50 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
51 3OAY 1 K, L Fab 2G12, light chain 9606  
52 3TCL 2 B, L CH04 Light Chain Fab 9606  
53 3QOT 1 L B3 (IGKV4-1) light chain 9606  
54 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
55 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
56 2HFF 1 A, L CB2 Fab, light chain 9606  
57 4M7K 1 L 10H10 light chain SEE REMARK 999 10090  
58 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
59 3L5X 1 L H2L6 LIGHT CHAIN 9606  
60 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
61 2R8S 2 L Fab light chain 10090  
62 4HKZ 1 A Trastuzumab light chain 9606  
63 3SO3 2 B A11 FAB light chain 9606  
64 3IDG 1 A 2F5 Fab light chain 9606  
65 3OAU 2 L Fab 2G12, light chain 9606  
66 4HIE 1 A Fab 023.102 9606  
67 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606  
68 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606  
69 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
70 4KMT 1 L light chain O12/KAPPA Fab 9606  
71 3NZH 1 L 5F6 LIGHT CHAIN 10090  
72 1RHH 1 A, C Fab X5, light chain 9606  
73 1TJG 1 L FAB 2F5 Light Chain 9606  
74 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606  
75 1RZ7 1 L Fab 48d light chain 9606  
76 1RZG 2 B, D Fab 412d heavy chain 9606  
77 3QOS 1 A, L B3 (IGKV4-1) light chain 9606  
78 3PGF 3 L SAB Light Chain 9606  
79 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606  
80 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
81 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
82 2QQN 3 L Antibody light chain 9606  
83 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
84 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
85 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606  
86 2CMR 3 L D5 9606  
87 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606  
88 3GRW 2 L Fab light chain 9606  
89 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
90 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606  
91 4LKC 1 A Fab fragment of PCSK9 antibody 9606  
92 4KZD 2 L BL3-6 Fab antibody, light chain 10090  
93 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606  
94 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
95 4HIH 1 A, C Fab 023.102 9606  
96 3DRQ 1 A 2F5 Fab' light chain 9606  
97 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
98 3D0V 1 A 2F5 Fab heavy chain 9606  
99 3S34 1 L 1121B Fab light chain 10090  
100 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
101 2F5B 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
102 1U8I 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
103 2AJ3 1 A, C, E Fab m18, Light Chain 9606  
104 3IDI 1 A 2F5 Fab light chain 9606  
105 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630  
106 4NRX 3 B, E, L m66 Light Chain 9606  
107 3O2D 1 L ibalizumab light chain 10090  
108 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606  
109 2R0L 1 L antibody light chain 32630  
110 1DN0 1 A, C IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN) FAB FRAGMENT 9606  
111 3GIZ 1 L Fab fragment of anti-CD20 antibody Ofatumumab, light chain 9606  
112 3Q1S 1 L Z13e1 Fab light chain 9606  
113 1U8H 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
114 2F5A 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
115 3KR3 3 L antibody-Fab (light chain) 9606  
116 2NY0 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
117 3MOA 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
118 2PR4 1 L nmAb 2F5 Fab' Heavy Chain 9606  
119 4D9Q 2 D, L Anti-Factor D, light chain 9606  
120 1YYM 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
121 2I5Y 2 L, Q Antibody 17B Light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
122 2FX9 1 L, M Fab 4E10 Light Chain 9606  
123 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090  
124 1TZG 1 L, M Fab 4E10 light chain 9606  
125 3W9D 2 B, D Antibody Fab light chain 9606  
126 1U95 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
127 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606  
128 3BN9 2 C, E E2 Fab Light Chain 9606  
129 4HWE 2 L Fab light chain light chain 9606  
130 1U8K 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
131 3L95 1 A, L anti-NRR1 fab fragment light chain 9606  
132 4OGX 3 L DX-2930 LIGHT CHAIN 9606  
133 3W9E 3 B Antibody Fab light chain 9606  
134 1OM3 1 L, M FAB 2G12, light chain light chain 9606  
135 4KZE 2 L BL3-6 Fab antibody, light chain 10090  
136 4HIJ 1 A, C Fab 023.102 light chain 9606  
137 3EYF 1 A, C 8f9 Fab 9606  
138 3NAB 1 L Fab15 Mut6 light chain 9606  
139 3IDN 1 A 2F5 Fab light chain 9606  
140 1RZ8 1 A, C Fab 17b light chain 9606  
141 4FNL 2 L, M Antibody C05, Light Chain 9606  
142 1U92 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
143 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606  
144 1BJ1 1 J, L FAB FRAGMENT HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090  
145 1U91 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
146 2FX8 1 L, M, N, O Fab 4E10 Light Chain 9606  
147 1NGY 1 A Mature Metal Chelatase Catalytic Antibody, Light chain Fab fragment 10090  
148 3IDX 3 L Fab b13 light chain 9606  
149 1U8Q 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
150 3IDJ 1 A 2F5 Fab light chain 9606  
151 3IDM 1 A 2F5 Fab light chain 9606  
152 1U8J 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
153 1ZLV 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
154 4K94 1 L Fab19 heavy chain 9606  
155 1ZLS 1 L FAB 2G12, light chain FAB, Light Chain 9606  
156 1I7Z 1 A, C CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION THE CHIMERA CONSISTS OF RESIDUES 1-108 OF MOUSE PORTION AND 109-214 OF HUMAN PORTION OF IG KAPPA CHAIN. 10090  
157 3D0L 1 A 2F5 heavy chain 9606  
158 4JPK 2 L Putative VRC01 germline precursor Fab light chain 9606  
159 3FCT 1 A, C PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY) CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606  
160 2P8L 1 A nmAb 2F5, light chain 9606  
161 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN FAB FRAGMENT 10090  
162 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090  
163 2I60 2 L, Q ANTIBODY 17B LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
164 4EDW 2 L tanezumab Fab light chain 9606  
165 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606  
166 2NY5 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
167 4NM4 1 L, M Antibody CR8043, Light Chain 9606  
168 1U8M 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
169 4D9R 2 D, L Fab light chain 9606  
170 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606  
171 4G7V 2 L fragment antibody light chain 9606  
172 4HFW 1 A, L 6-26 Fab Light chain 9606  
173 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
174 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606  
175 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090  
176 4KQ4 1 L CNTO7357 light chain Fab (mouse variable domain, human constant domain) 10090  
177 3INU 2 L, N KZ52 antibody fragment light chain 9606  
178 3LEV 2 L 2F5 ANTIBODY LIGHT CHAIN 9606  
179 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606  
180 1RZJ 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606  
181 4HII 1 A, C Fab 023.102 light chain 9606  
182 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606  
183 4DN3 1 L CNTO888 LIGHT CHAIN 9606  
184 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606  
185 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606  
186 3MOB 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
187 3EYV 1 A, L hu3S193 Fab, light chain 10090  
188 1GC1 3 L ANTIBODY 17B MONOCLONAL ANTIBODY 17B BINDS TO A CD4-INDUCED SITE ON GP120 ANTIGEN-BINDING FRAGMENT, FAB 9606  
189 3BDY 2 L Fab Fragment -Light Chain 9606  
190 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606  
191 1G9M 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
192 3K2U 4 L Antibody, Fab fragment, Light Chain 9606  
193 1U8N 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
194 4HWB 3 L Fab light chain 9606  
195 1U93 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
196 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090  
197 2HFG 1 L CB3s Fab light chain (kappa) 9606  
198 3GKW 2 L Light chain of the antibody Nimotuzumab 9606  
199 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606  
200 4JQI 3 L Fab30 light chain 10090  
201 3SKJ 1 L, M Antibody, light chain 9606  
202 3U30 2 B, E Light chain Fab 9606  
203 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606  
204 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606  
205 2NYY 2 C CR1 monoclonal antibody light chain 9606  
206 2GCY 1 A huC25 fab fragment light chain 10090  
207 4JLR 2 B, L Motavizumab Fab light chain 9606  
208 2QQK 3 L Antibody Light Chain 9606  
209 4J1U 1 A, C, E antibody 93F3 Light chain 10090  
210 2PW2 1 A 2F5 Fab' heavy chain 9606  
211 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090  
212 2PW1 1 A 2F5 Fab fragment heavy chain 9606  
213 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606  
214 4KXZ 3 I, L, M, P GC1008 Light Chain 9606  
215 1TZH 2 A, L Fab YADS1 Light Chain 10090  
216 4JZJ 3 B, L Fab Light Chain 10090  
217 4M6O 1 L CNTO7309 light chain 9606  
218 4DVR 2 L Fab 48d Light chain 9606  
219 3EYQ 1 C M2J5 Fab 9606  
220 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606  
221 1YYL 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606  
222 1U8L 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
223 2NY6 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
224 3DVG 1 A Human IgG1 fab fragment light chain 9606  
225 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606  
226 2AGJ 1 L Yvo Fab, Light Chain 9606  
227 3EYO 1 A, C 8f9 Fab 9606  
228 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606  
229 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606  
230 3B2U 1 D, G, K, L, O, R, U, X IMC-11F8 Fab Light chain 9606  
231 4DN4 1 L CNTO888 LIGHT CHAIN 9606  
232 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606  
233 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090  
234 2FJG 2 A, L Fab light chain 9606  
235 4DKF 3 L, M FAb2 Light Chain 9606  
236 1UWE 2 L, U, X ANTIBODY 14D9 FAB LIGHT CHAIN, RESIDUES 1-212 10090  
237 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606  
238 1IT9 1 L HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN FAB FRAGMENT 10090  
239 3EFD 1 L FabL 10090  
240 4LF3 1 A, D Fab heavy chain 10090  
241 1UWG 2 L, X ANTIBODY 14D9 CATALYTIC ANTIBODY 19C9 FAB LIGHT CHAIN, RESIDUES 1-213 10090  
242 4LEO 2 B RG7116 Fab light chain 10090  
243 4G7Y 2 L Fragment antibody light chain 9606  
244 4PY8 4 J antibody 3.1 light chain Fab 9606  
245 3SDY 4 L Antibody CR8020, Light Chain 9606  
246 3DVN 1 A, L Human IgG1 fab fragment light chain 9606  
247 3IXT 1 B, L Motavizumab Fab light chain 10090  
248 2P8M 1 A nmAb 2F5, light chain 9606  
249 4NP4 3 L, M bezlotoxumab light chain 9606  
250 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598  
251 4ERS 1 L Fab light chain 9606  
252 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606  
253 4MWF 2 B, L Fab AR3C light chain 9606  
254 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606  
255 3SQO 3 L J16 Light chain 9606  
256 4K3J 4 L Onartuzumab Fab light chain 10090  
257 4PS4 1 L M1295 LIGHT CHAIN 9606  
258 3HI1 2 A, L F105 Light Chain 9606  
259 4PY7 2 B, J antibody 3.1 light chain Fab 9606  
260 4K8R 3 C Fab1, light chain 9606  
261 1RZK 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606  
262 1ZLU 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
263 1G9N 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
264 1TZI 1 A Fab YADS2 Light Chain 10090  
265 1QLR 1 A, C IGM KAPPA CHAIN V-III (KAU COLD AGGLUTININ) FAB FRAGMENT 9606  
266 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090  
267 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606  
268 1MHP 3 L, Y FAB FRAGMENT, light chain 10090  
269 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544  
270 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606  
271 2QQL 3 L Antibody Light Chain 9606  
272 2P8P 1 A nmAb 2F5, light chain 9606  
273 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606  
274 3WD5 2 L Adalimumab Light Chain 9606  
275 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606  
276 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606  
277 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606  
278 1ZLW 1 K, L FAB 2G12, light chain FAB, Light Chain 9606  
279 4HFU 4 L Fab 8M2 light chain 9606  
280 4FP8 3 L, M, N, O Antibody C05, light chain 9606  
281 3BE1 3 L Fab Fragment-Light Chain 9606  
282 2FJH 2 A, L Fab fragment light chain 9606  
283 4K9E 1 L light chain 10090  
284 3P0V 1 L, M Fab DL11 light chain 9606  
285 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606  
286 1U8O 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
287 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606  
288 4KVN 3 L Human IgG Light Chain 9606  
289 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606  
290 3OB0 1 K, L Fab 2G12, light chain Fab 9606  
291 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606  
292 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606  
293 4I18 1 B, L antibody light chain Fab 10090  
294 3KYM 1 A, C, E, G, I, K, M, O Light Chain Li33 IgG2 9606  
295 3IDY 3 C, L Fab b13 light chain 9606  
296 4OQT 2 L Light Chain of Li81 Fab, kappa 3 9606  
297 3IVK 1 B, L Fab light chain man 10090  
298 3KYK 2 L Light Chain Li33 IgG1 9606  
299 4IRZ 2 L Fab Natalizumab light chain 9606  
300 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606  
301 2R56 2 L, M IgE Fab Fragment, light chain 9606  
302 1ZA6 1 A, C, E, G IGG Light chain 9606  
303 1U6A 1 L F105 LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
304 1NGW 1 A, L Mature Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
305 4P59 3 L MOR09825 Fab fragment light chain 9606  
306 4LMQ 3 I, L Stromal cell-derived factor 1 9606  
307 3N85 2 L Fab37 Light Chain 9606  
308 3G6J 3 E, G Fab light chain 9606  
309 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606  
310 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606  
311 4DKE 3 L, M FAb1.1 Light Chain 9606  
312 3DRT 1 A 2F5 Fab' light chain 9606  
313 1U8P 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
314 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606  
315 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606  
316 1I9R 3 L, M, Y IMMUNOGLOBULIN L 9606  
317 4NRY 1 B, L m66 Heavy Chain 9606  
318 3S37 1 L 1121B Fab light chain 10090  
319 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090  
320 4JM2 3 C 17b Light chain Fab 9606  
321 1S78 2 C, E Pertuzumab Fab light chain 10090  
322 1OP5 1 K, L FAB 2G12, light chain light chain 9606  
323 4N90 3 E, G, I Fab light chain 9606  
324 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606  
325 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598  
326 3EO1 1 A, D, G, J GC-1008 Fab Light Chain 10090  
327 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090  
328 4IOF 3 D, F Fab-bound IDE, light chain 10090  
329 4JHW 2 L D25 light chain 9606  
330 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606  
331 3BQU 1 A 2F5 Fab' light chain 9606  
332 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606  
333 4M1C 3 D, F Fab-bound IDE, light chain 9606  
334 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606  
335 3ULV 2 L Fab15 light chain 9606  
336 4M7L 2 L 10H10 light chain SEE REMARK 999 10090  
337 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606  
338 3EGS 1 A 2F5 Fab' light chain 9606  
339 2NZ9 2 C, E AR2 monoclonal antibody light chain 9606  
340 3S36 1 L 1121B light chain 10090  
341 3DRO 1 A 2F5 Fab light chain 9606  
342 2R0K 2 L antibody light chain of Fab58 9606  
343 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606  
344 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606  
345 4G80 3 B, D, F, H fragment antibody light chain 9606  
346 3JWO 3 L FAB 48D LIGHT CHAIN 9606  
347 3P11 2 L Fab DL11 light chain 9606  
348 3F12 1 A, C M2J1 Fab 9606  
349 3B2V 1 L IMC-11F8 FAB Light chain 9606  
350 3ULU 2 L Fab15 light chain 9606  
351 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606  
352 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606  
353 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606  
354 2B4C 3 L anti-HIV-1 gp120 immunoglobulin X5 light chain 9606  
355 3EFF 1 A, C FAB 10090  
356 3PJS 1 A, C FAB light chain 10090  
357 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606  
358 4R4H 3 L Antibody 2.2c, Light chain 9606  
359 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606  
360 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606  
361 3CM9 3 L, M, N, O Ig alpha-2 chain C region 9606  
362 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606  
363 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606  
364 2ESG 1 L, M Immunoglobulin A1 light chain 9606  
365 1R70 1 A, C Human IgA2(m1) Light Chain 9606  
366 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606  
 
Sequence Clusters for the Sequence Entities in PDB 1G9N
Entity #1: Chains: G - ENVELOPE GLYCOPROTEIN GP120 protein, length: 313 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 6 6 4385
95% 6 6 4988
90% 8 9 3140
70% 22 27 1157
50% 22 27 1221
40% 22 27 1256
30% 22 29 1158
Entity #2: Chains: C - T-CELL SURFACE GLYCOPROTEIN CD4 protein, length: 185 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 21 28 925
95% 25 33 985
90% 25 33 1009
70% 25 33 1041
50% 25 33 1110
40% 25 33 1137
30% 25 33 1124
Entity #3: Chains: L - ANTIBODY 17B, LIGHT CHAIN protein, length: 214 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 2 2 30357
95% 19 20 1588
90% 263 366 4
70% 942 1292 3
50% 2232 3072 1
40% 2233 3073 1
30% 2597 3633 1
Entity #4: Chains: H - ANTIBODY 17B, HEAVY CHAIN protein, length: 229 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 2 2 29422
95% 19 20 1584
90% 19 20 1632
70% 1076 1481 2
50% 2233 3072 1
40% 2234 3073 1
30% 2598 3633 1
 

Documentation

Click here for more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB.